Impact of Incomplete Endometrial Ablation

Status Enrolling by invitation

Clinical Trial Summary

The aim of the proposed protocol is to study the impact of incomplete endometrial ablation on the PBAC score, reintervention, satisfaction, controlled bleeding and dysmenorrhea at 24 months after Novasure endometrial ablation, in women with heavy menstrual bleeding treated at Máxima Medical Centre Veldhoven, in The Netherlands.

Clinical Trial Description

The primary outcome is blood loss at 24 months after treatment, measured with the PBAC-score according to Higham. To calculate this score women were asked, in the MIRA and MIRA2 study, to record their menstrual blood loss for one month counting the number of super tampons or pads used each day. The total score was calculated using a score of 1 for each lightly saturated tampons. For pads the scores were respectively 1, 5 and 20. Secondary outcome measures were controlled bleeding, defined as a PBAC-score not exceeding 75 points, PBAC score of zero, re-intervention rate 24 months after treatment, satisfaction with treatment (measured with a 5-point Likert scale) and dysmenorrhea. In addition, multiple variables were analyzed in predicting the occurrence of incomplete endometrial ablation, including age, BMI, cavum length, cavum width, ablation time, ablation power, nulliparity, sterilization in history, section caesarea in history, position of the uterus (AVF/RVF), presence of myomas, the presence of adenomyosis and surgery under local anesthesia, generally without sterilization or generally in combination with sterilization. Information was collected from EPD and the MIRA and MIRA2 databases. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06122363
Study type	Observational
Source	Maxima Medical Center
Contact
Status	Enrolling by invitation
Phase
Start date	March 1, 2023
Completion date	December 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02934789` - Effectiveness of Truclear on Patient Quality of Life	N/A
Completed	`NCT02925494` - An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Recruiting	`NCT04959396` - IUB SEAD RED (Revolutionary Endometrial Ablation Device Study	N/A
Active, not recruiting	`NCT04778072` - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects	N/A
Terminated	`NCT05026502` - A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
Recruiting	`NCT06064851` - Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Von Willebrand Disease Patients	N/A
Terminated	`NCT04132349` - Ulipristal Acetate in Symptomatic Uterine Fibroid	Phase 4
Completed	`NCT00386308` - Efficacy and Safety Study of XP12B in Women With Menorrhagia	Phase 3
Completed	`NCT03412890` - LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Active, not recruiting	`NCT04477837` - Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
Completed	`NCT05176496` - A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment
Completed	`NCT01431326` - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed	`NCT00401193` - Efficacy and Safety of XP12B in Women With Menorrhagia	Phase 3
Completed	`NCT03317795` - Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids	Phase 4
Completed	`NCT02943655` - Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause	Phase 3
Completed	`NCT03070951` - Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Recruiting	`NCT05685199` - Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
Completed	`NCT05406960` - Therapeutic Effect of Herbal Infusion on Menometrorrhagia	N/A
Not yet recruiting	`NCT05079815` - Heavy Menstrual Bleeding and Iron Deficiency Anemia
Active, not recruiting	`NCT02449304` - Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device	Phase 4